Images List Premium Download Classic

Dextran

Dextran-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Compositions and methods for the removal of sulfates and metals from waste water
Hppe, Llc
June 15, 2017 - N°20170166462

The invention is directed to compounds, compositions and methods for the removal of contaminants from fluids and, in particular sulfates and/or metals from industrial waste water. Compounds and compositions of the invention contain polysaccharides and other organic molecules. These flocculating agents are safe and effective, requiring no special handling procedures. Flocculation compounds include biopolymers of dextran, modified dextran and ...
Membrane for blood purification
Gambro Lundia Ab
June 15, 2017 - N°20170165616

The present disclosure relates to semipermeable membranes which are suitable for blood purification, e. G. By hemodialysis, which have an increased ability to remove larger molecules while at the same time effectively retaining albumin. The membranes are characterized by a molecular retention onset (mwro) of between 9. 0 kd and 14. 5 kd and a molecular weight cut-off (mwco) of between 55 kd and 130 kd ...
Recovery of mining processing product using boronic acid-containing polymers
Ecolab Usa Inc.
June 08, 2017 - N°20170158522

Methods and compositions for improving performance of flocculants in an industrial production process. Methods include ph triggered cross-linking reaction between a flocculating agent, such as dextran, and a composition comprising a boronic acid-containing polymer. The ph trigger can be provided by a fluid having a ph of 8 or more. The production process can be a bayer process and the fluid ...
Dextran Patent Pack
Download + patent application PDFs
Dextran Patent Applications
Download + Dextran-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dextran-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Erythrocyte aggregation and leukocyte isolation
General Electric Company
June 01, 2017 - N°20170153223

A device and/or methodology are described that include a mechanism for separating erythrocytes from other constituents of blood and for purifying leukocytes from blood. The separation and purification aspects may be provided in separate components or within the same component. The separation aspect assists in separating erythrocytes (red blood cells) from other cells in blood, such as by aggregation ...
Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly alpha-1,2 branched dextran
Institut National Des Sciences Appliquees (insa)
June 01, 2017 - N°20170152489

The invention relates to an isolated polypeptide with an glycosyl transferase enzymatic activity for producing dextrans with . Alpha.(1. Fwdarw. 2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan. The invention further relates to polynucleotides coding for said enzymes and vectors containing the same.
The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenesis ...
Tx Medic Ab
June 01, 2017 - N°20170151275

The present embodiments relate to the use of dextran sulfate having an average molecular weight below 10 000 da for inducing angiogenesis in a subject and for increasing blood flow in a subject suffering from ischemia.
Dextran Patent Pack
Download + patent application PDFs
Dextran Patent Applications
Download + Dextran-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dextran-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Multi-layered anti-adhesion device
Tx Medic Ab
May 25, 2017 - N°20170143874

Compositions and methods are provided for preparing an adhesion barrier in the form of a foldable or flexible biodegradable polymer matrix that effectively reduces, prevents or treats adhesions in a patient in need thereof. In one embodiment, the matrix comprises a first porous layer comprising collagen and a second porous layer comprising collagen and dextran, wherein the dextran is loaded ...
Method of sealing a durotomy
St. Teresa Medical, Inc.
May 18, 2017 - N°20170136141

A method of sealing a durotomy from which cerebrospinal fluid is leaking. A durotomy sealant dressing is prepared by applying an active agent to a dextran base. The durotomy sealant dressing is applied to a durotomy. At least a portion of the durotomy sealant dressing dissolves. The durotomy is sealed with the dissolved durotomy sealant dressing to substantially prevent cerebrospinal ...
Insulin-containing prolonged-action preparation
Obschestvo S Ogranchennoj Otvetctvennostu "biosabtek"
May 18, 2017 - N°20170136096

The invention relates to the field of biotechnology and medicine, and specifically to insulin-containing injectable formulations used, in particular, for treating diabetes mellitus. The present formulation comprises insulin and a pharmacologically acceptable polymer having a hydrodynamic diameter of more than 4. 5+/−0. 5 nanometers. As said polymer, at least one polymer having a molecular weight of 20-70 kda may be optimally used, ...
Conjugates comprising an anti-egfr1 antibody
Tenboron Oy
April 27, 2017 - N°20170112931

The present invention relates to a conjugate comprising an anti-egfr1 antibody or an egfr binding fragment thereof and at least one dextran derivative, wherein the dextran derivative comprises at least one d-glucopyranosyl unit, wherein at least one carbon selected from carbon 2, 3 or 4 of the at least one d-glucopyranosyl unit is substituted by a substituent of the formula —o—(...
Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
Tate & Lyle Ingredients France Sas
April 13, 2017 - N°20170101484

Compositions for improving the health of a subject comprise alpha-(1,2)-branched alpha-(1,6) oligodextrans, preferably with an average molecular weight between about 10 kda and 70 kda, between about 10% and 50% alpha-(1,2)-osidic side chains, and having at least partial indigestibility in the subject. Methods for improving the health of a subject comprise administering the composition to a subject in an amount effective to ...
Methods and systems of assessing tissue vascular permeability using non-labeled dextran
The Johns Hopkins University
March 16, 2017 - N°20170074958

A method of assessing tissue vascular permeability for nanotherapeutics using non-labeled dextran can include: receiving a non-labeled, physiologically-tolerable dextran solution by a subject; acquiring a plurality of magnetic resonance images of a distribution of the dextran solution within at least one region of interest of the subject for a corresponding plurality of times; and assessing a tissue vascular permeability of ...
Hydrogel composition
New Jersey Institute Of Technology
February 23, 2017 - N°20170050172

A hydrogel composition is provided that includes crosslinked dextran and dextran sulfate. The hydrogel composition may be included in a matrix that includes an osmotically active material immobilized in the matrix. The hydrogel composition can be combined into superabsorbent preparations that are capable of adsorbing large amounts of water. The superabsorbent preparations have advantages in the use of absorbent materials ...
Dextran Patent Pack
Download + patent application PDFs
Dextran Patent Applications
Download + Dextran-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dextran-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Fat replacers and filling materials
Cargill, Incorporated
February 02, 2017 - N°20170027209

The present invention relates generally to fat replacers and their use in various food products. Aspects of the disclosure are particularly directed to oligodextran-based fat replacers that are lower in calories, heat stable, and increase fiber. They can either be used alone or in combination with other additives to decrease the fat content while maintaining good organoleptic properties.
High sensitive detection of melatonin
Koninklijke Philips N.v.
January 26, 2017 - N°20170023593

The present invention relates to the use of a derivative of melatonin in an assay, wherein said derivative is a conjugate at position 3 of melatonin's indole ring and wherein said conjugate comprises a linker of at least 2 carbon atoms, with the proviso that the conjugate does not comprise a polypeptide or protein antigen. The derivative preferably comprises 3-(2-ethylamidoglutaric acid)...
Method for the production of dextran
Bio-e.r.g. S.r.l.
December 01, 2016 - N°20160348140

Method for the production of dextran comprising the following steps: prepare a culture medium containing the appropriated mixture and balance of ingredients, mainly after accurate selection of nature and concentration of carbon and nitrogen sources, with a specific initial ph, inoculate the culture medium with an appropriated quantity of bacteria strain (to standardize the production and avoid as much as ...
Process for producing and purifying factor viii and its derivatives
Sk Chemicals Co., Ltd.
December 01, 2016 - N°20160347819

Disclosed is a method for producing proteins having factor viii procoagulant activity in serum-free medium by in vitro culturing of mammalian cells, wherein the serum-free medium contains an inhibitor against the protease released from cultured cells. In accordance with this invention, the inhibitor can protect the cleavage of a target protein during cultivation and increase homogeneity of a target molecule, ...
Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
Navidea Biopharmaceuticals, Inc.
December 01, 2016 - N°20160347679

The subject invention relates to the compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran with technetium-99m and for stabilizing the dtpa-dextran cold kit. The composition contains stannous chloride ions to reduce 99mtc-pertechnetate, ascorbic acid to reduce stannic ions to stannous ions to maintain a reducing environment, α,α-trehalose to add bulk and to stabilize the lyophilized composition ...
Medical fluid, a method of treatment and use of the fluid
Vivoline Medical Ab
November 24, 2016 - N°20160338343

A medical fluid for a harvested organ, tissue or part thereof, for evaluation and/or preservation. The fluid includes cocaine or a stimulating analogue thereof; noradrenaline; and/or adrenaline. In addition, the fluid includes an oncotic agent, such as dextran; hormones, such as thyroxin; triiodotyronine; cortisone, insulin; and electrolytes and optionally nutrients in substantially physiological concentrations in a physiologically acceptable ...
Anti-microbial agents and uses therefor
Ucl Business Plc
November 10, 2016 - N°20160324939

The invention relates generally to methods and materials (for example animal feeds) which use dextranases for treating or controlling campylobacter infection or colonisation, or disrupting campylobacter biofilms. The invention has utility inter alia in eradicating or reducing the prevalence of campylobacter in a population of animals, such as poultry.
Method and kit for detection of microorganism
Ucl Business Plc
October 13, 2016 - N°20160298181

3) a primer or primers for amplifying a target region of the dna or rna of the microorganism to be detected by a nucleic acid amplification method. The agent for suppressing a nucleic acid amplification inhibitory substance is one or more selected from albumin, dextran, t4 gene 32 protein, acetamide, betaine, dimethyl sulfoxide, formamide, glycerol, polyethylene glycol, soybean trypsin inhibitor, α2...
Loading